Previous Close | 1.0200 |
Open | 1.0200 |
Bid | 0.9800 x 0 |
Ask | 1.0000 x 0 |
Day's Range | 0.9700 - 1.0200 |
52 Week Range | 0.4720 - 1.8900 |
Volume | |
Avg. Volume | 403,938 |
Market Cap | 202.566M |
Beta (5Y Monthly) | 1.01 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0700 |
Earnings Date | Nov 11, 2020 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 2.20 |
SERSTECH GROUP, 1 APRIL – 30 JUNE 2024 Net sales amounted to KSEK 21 369 (32 775). EBITDA amounted to KSEK 5 595 (16 064), corresponding to an EBITDA margin of 26%. EBIT amounted to KSEK 3 715 (13 084), corresponding to an EBIT margin of 17%. Cash flow from operating activities amounted to KSEK -1 112 (-8 191). Earnings per share amounted to SEK 0.02 (0.06). Earnings per average number of shares amounted to SEK SEK 0.02 (0.06). SERSTECH GROUP, 1 JANUARY – 30 JUNE 2024 Net sales amounted to KSEK
Serstech has today received an order of 5.6 MSEK from its US partner Proengin Inc. The order consists of Serstech Arx instruments, the patented SERS kit, Serstech ChemDash software and substance libraries. This is the second order from the same end-customer within one year. The order will be delivered and invoiced in June 2024. For further information, please contact: Stefan Sandor,CEO, Serstech AB Phone: +46 739 606 067Email: ss@serstech.comorThomas Pileby,Chairman of the Board, Serstech AB Pho